Protamine Goes in to Reverse the Heparin — and His Pulmonary Artery Pressure Doubles
Coming off bypass, the protamine that's supposed to close out the case instead nearly closes his right heart down. This isn't the titrated-dosing question that comes up before protamine is ever given — it's what to do once a catastrophic reaction is already underway.
G.M., a 67-year-old man, is coming off cardiopulmonary bypass following a three-vessel coronary artery bypass graft — weaned successfully, hemodynamically stable, cannulae not yet out — when protamine is given to reverse his intraoperative heparin per the standard closing protocol. Within ninety seconds his pulmonary artery pressure, a normal 22/10 off bypass, spikes to 58/32; his right ventricle visibly distends on the surgeon's direct view of the exposed heart; and his systemic blood pressure collapses to 58/30 as right heart output falls off a cliff. He had an uneventful coronary bypass at a different hospital eleven years ago, protamine included — a detail the team learns from his wife in the family-update room rather than from his chart, since the outside records were never formally requested for a case that looked routine going in. It is not the reassurance it sounds like. Protamine reactions, the catastrophic pattern included, can occur on repeat exposure with no identifiable prior sensitizing event, and a clean history does not predict them the way it does for some other drug reactions.
This is not the more familiar protamine hypotension from rapid histamine release, nor classic IgE-mediated anaphylaxis in a fish-allergic or NPH-insulin-exposed patient — the specific pattern of acute, severe pulmonary vasoconstriction with right ventricular failure is the Type III reaction in Horrow's classification of protamine toxicity, driven by thromboxane release and complement activation constricting pulmonary vascular smooth muscle directly, a mechanism genuinely distinct from the systemic vasodilation of Horrow's Type I. That Type I picture is the version most anesthesiologists have actually seen, which is precisely why the reflex it trains is the wrong one here: volume loading and a systemic vasopressor, the instinctive first response to any post-bypass hypotension, do little for a right ventricle failing specifically because its afterload has acutely doubled, and may worsen RV distension further unless paired with something that actually reduces pulmonary vascular resistance. The team has no warning sign it could have caught beforehand, only a crisis that has already declared itself.
In the OR, ninety seconds after protamine
This is a Type III catastrophic protamine reaction — acute pulmonary vasoconstriction and right heart failure, mechanistically distinct from ordinary histamine-mediated protamine hypotension or IgE anaphylaxis. Treat it as pulmonary hypertensive crisis with RV failure, not as generic anaphylaxis: inhaled nitric oxide now to reduce pulmonary vascular resistance directly, plus epinephrine for RV inotropic support, not volume loading alone.
His pressure is 58/30 with a visibly distended, failing right ventricle right in front of me — I don't think pharmacologic measures alone have time to work here. The cannulae aren't out yet; re-heparinize and go back on bypass now. That removes the afterload problem entirely rather than trying to out-drug a right heart that may not tolerate waiting to see if the nitric oxide takes effect.
We don't have to choose between those — start the inhaled nitric oxide and epinephrine right now while the perfusion team simultaneously preps to go back on bypass. Getting bypass access ready takes real time regardless of whether we ultimately need it; running both in parallel costs us nothing if the pharmacologic measures work and saves us the critical minutes if they don't.
Agreed and executed in parallel: inhaled nitric oxide and titrated epinephrine started within the first minute while the perfusion team simultaneously prepared for possible return to bypass. His pulmonary artery pressure began falling within three minutes and systemic pressure recovered to 92/58 by minute five; return to bypass was ultimately not required.
The reaction was documented explicitly as Type III catastrophic protamine reaction, distinct from his prior uneventful protamine exposure at a different institution years earlier — flagged clearly in his chart for any future cardiac surgery, alongside a note that a slower, more titrated protamine administration would be used for any subsequent exposure, a distinct dosing question from tonight's crisis management itself.